Recombinant production means the target peptide or protein is expressed by a living host cell engineered to carry its gene, rather than assembled chemically. Typical hosts are E. coli, Pichia or Saccharomyces yeast, and mammalian CHO lines; the product is then extracted, refolded if necessary, and purified by chromatography.
Why recombinant matters in peptide research
Length decides the route. Chemical solid-phase synthesis is efficient to roughly 50 residues, beyond which cumulative coupling losses make yields impractical; recombinant expression handles long chains and whole proteins comfortably and can install disulfide bonds and, in eukaryotic hosts, glycosylation. Insulin, growth hormone and full-length thymosin beta-4 are recombinant products, while short signalling peptides and fragments are synthetic.
The impurity profiles differ, and that drives what a certificate of analysis should report. Synthetic material carries deletion sequences and residual solvents; recombinant material carries host cell protein, host DNA and — for bacterial hosts — endotoxin, which must be tested separately because HPLC purity will not reveal it. Recombinant material is also more prone to lot-to-lot variability. See how to read a COA.